Nantong Jinghua Pharmaceutical Co Ltd (002349) — Net Asset Quality Index
Nantong Jinghua Pharmaceutical Co Ltd (002349) has a Net Asset Quality Index of 89.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.63 Billion minus total liabilities of CN¥392.26 Million yields net assets of CN¥3.24 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Nantong Jinghua Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Nantong Jinghua Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2006–2025)
This chart shows how Nantong Jinghua Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the index stands at 89.2%, representing net assets of CN¥3.24 Billion against total assets of CN¥3.63 Billion CNY. See 002349 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 002349 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.2% | CN¥3.15 Billion | CN¥3.57 Billion | CN¥421.13 Million | ▼ -1.4 pp |
| 2024 | 89.6% | CN¥2.96 Billion | CN¥3.30 Billion | CN¥344.66 Million | ▲ +1.5 pp |
| 2023 | 88.0% | CN¥2.80 Billion | CN¥3.19 Billion | CN¥380.75 Million | ▲ +1.8 pp |
| 2022 | 86.3% | CN¥2.62 Billion | CN¥3.04 Billion | CN¥417.93 Million | ▲ +5.9 pp |
| 2021 | 80.3% | CN¥2.57 Billion | CN¥3.20 Billion | CN¥628.54 Million | ▲ +1.6 pp |
| 2020 | 78.8% | CN¥2.49 Billion | CN¥3.16 Billion | CN¥669.29 Million | ▲ +5.8 pp |
| 2019 | 73.0% | CN¥2.15 Billion | CN¥2.94 Billion | CN¥793.62 Million | ▼ -6.2 pp |
| 2018 | 79.3% | CN¥2.69 Billion | CN¥3.40 Billion | CN¥705.27 Million | ▼ -2.4 pp |
| 2017 | 81.7% | CN¥2.65 Billion | CN¥3.24 Billion | CN¥594.47 Million | ▼ -9.3 pp |
| 2016 | 91.0% | CN¥2.30 Billion | CN¥2.53 Billion | CN¥227.87 Million | ▲ +1.9 pp |
| 2015 | 89.1% | CN¥2.23 Billion | CN¥2.51 Billion | CN¥272.27 Million | ▲ +7.8 pp |
| 2014 | 81.3% | CN¥1.53 Billion | CN¥1.89 Billion | CN¥351.96 Million | ▲ +12.1 pp |
| 2013 | 69.3% | CN¥741.83 Million | CN¥1.07 Billion | CN¥328.99 Million | ▼ -5.4 pp |
| 2012 | 74.6% | CN¥714.87 Million | CN¥957.71 Million | CN¥242.84 Million | ▼ -6.9 pp |
| 2011 | 81.5% | CN¥636.30 Million | CN¥780.53 Million | CN¥144.23 Million | ▼ -7.5 pp |
| 2010 | 89.0% | CN¥544.45 Million | CN¥611.41 Million | CN¥66.96 Million | ▲ +26.8 pp |
| 2009 | 62.2% | CN¥137.11 Million | CN¥220.37 Million | CN¥83.26 Million | ▲ +1.7 pp |
| 2008 | 60.6% | CN¥118.66 Million | CN¥195.95 Million | CN¥77.29 Million | ▲ +14.7 pp |
| 2007 | 45.9% | CN¥91.86 Million | CN¥200.11 Million | CN¥108.25 Million | ▲ +10.6 pp |
| 2006 | 35.3% | CN¥70.00 Million | CN¥198.19 Million | CN¥128.18 Million | — |